Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Echo Therapeutics Inc (NASDAQ:ECTE)

1.62
Delayed Data
As of May 26
 -0.02 / -1.22%
Today’s Change
0.88
Today|||52-Week Range
2.40
+14.08%
Year-to-Date
No recent news for Echo Therapeutics Inc.

Today’s Trading

Previous close1.64
Today’s open1.65
Day’s range1.58 - 1.65
Volume5,596
Average volume (3 months)33,010
Market cap$18.7M
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-59.68%
Earnings growth (this year)--
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc+0.07+7.53%
NEOTNeothetics Inc-0.13-9.92%
ACSTAcasti Pharma Inc-0.18-10.78%
CAPNCapnia Inc+0.08+6.26%
Data as of 3:49pm ET, 05/26/2016

Financials

Last reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$0.00
Annual profit (last year)-$22.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Scott Wayne Hollander
Vice President-Operations &
Product Development
Thomas H. Bishop
Corporate headquarters
Iselin, New Jersey

Forecasts

Partner Offers

Search for Jobs